HMGB1 and hepatocellular carcinoma: However, HN1 (Hematological and neurological expressed 1) can competitively bind to TRIM28, thereby inhibiting the degradation of HMGB1, promoting the proliferation and metastasis of HCC, and reducing chemotherapy sensitivity to oxaliplatin (Wang et al., 2022).